Michael H. Carrel's Insider Trades & SAST Disclosures
Michael H. Carrel's most recent trade in Atricure Inc was a trade of 4,000 Common Stock done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael H. Carrel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Mar 2025 | 4,000 | 706,555 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 50,907 | 754,481 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 50,335 | 703,574 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.74 per share. | 01 Mar 2025 | 43,926 | 710,555 (1%) | 0% | 38.7 | 1,701,693 | Common Stock |
| Axonics Inc | Michael H. Carrel | Director | Sale or transfer of securities back to the company at price $ 71.00 per share. | 15 Nov 2024 | 17,861 | 0 (0%) | 0% | 71 | 1,268,131 | Common Stock |
| Axonics Inc | Michael H. Carrel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Axonics Inc | Michael H. Carrel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2024 | 3,000 | 653,239 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 19.35 per share. | 28 Jun 2024 | 707 | 656,239 (1%) | 0% | 19.3 | 13,680 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2024 | 2,000 | 655,532 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 69,142 | 705,356 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 50,854 | 636,214 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.28 per share. | 01 Mar 2024 | 47,824 | 657,532 (1%) | 0% | 36.3 | 1,735,055 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Nov 2023 | 10,000 | 585,360 (1%) | 0% | 0 | Common Stock | |
| Axonics Inc | Michael H. Carrel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2023 | 500 | 17,861 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Aug 2023 | 1,250 | 595,360 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 38.11 per share. | 30 Jun 2023 | 557 | 596,610 (1%) | 0% | 38.1 | 21,227 | Common Stock |
| Axonics Inc | Michael H. Carrel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 3,000 | 18,361 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 May 2023 | 1,000 | 596,053 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 69,234 | 598,130 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 45,993 | 644,123 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.81 per share. | 01 Mar 2023 | 45,470 | 598,653 (1%) | 0% | 38.8 | 1,764,691 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2023 | 800 | 597,053 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Mar 2023 | 800 | 597,853 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 17 Nov 2022 | 6,000 | 528,896 (1%) | 0% | 0 | Common Stock | |
| Axonics Inc | Michael H. Carrel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 2,100 | 15,361 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 34.73 per share. | 30 Jun 2022 | 350 | 534,896 (1%) | 0% | 34.7 | 12,156 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 67,109 | 555,081 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.59 per share. | 01 Mar 2022 | 43,167 | 534,546 (1%) | 0% | 69.6 | 3,003,992 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 22,632 | 577,713 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2022 | 510 | 487,972 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2022 | 510 | 488,482 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Dec 2021 | 10,000 | 488,851 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2021 | 345 | 499,196 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2021 | 345 | 498,851 (1%) | 0% | 0 | Common Stock | |
| Axonics Inc | Michael H. Carrel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 2,261 | 13,261 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 45.72 per share. | 30 Jun 2021 | 251 | 499,541 (1%) | 0% | 45.7 | 11,476 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.31 per share. | 01 Mar 2021 | 55,241 | 499,290 (1%) | 0% | 66.3 | 3,663,031 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 29,378 | 534,173 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 20,358 | 554,531 (1%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 63.00 per share. | 10 Feb 2021 | 25,000 | 504,795 (1%) | 0% | 63 | 1,575,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 25,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 10 Feb 2021 | 25,000 | 504,795 (1%) | 0% | 65 | 1,625,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 10 Feb 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 64.00 per share. | 10 Feb 2021 | 25,000 | 504,795 (1%) | 0% | 64 | 1,600,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 10 Feb 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 10 Feb 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 25,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 25,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 08 Feb 2021 | 25,000 | 504,795 (1%) | 0% | 62 | 1,550,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 08 Feb 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 61.00 per share. | 08 Feb 2021 | 25,000 | 504,795 (1%) | 0% | 61 | 1,525,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 08 Feb 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 02 Feb 2021 | 25,000 | 504,795 (1%) | 0% | 60 | 1,500,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 25,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 02 Feb 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2021 | 25,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 11 Jan 2021 | 25,000 | 504,795 (1%) | 0% | 59 | 1,475,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 11 Jan 2021 | 25,000 | 529,795 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 58.00 per share. | 23 Dec 2020 | 24,953 | 504,504 (1%) | 0% | 58 | 1,447,274 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 23 Dec 2020 | 24,953 | 529,457 (1%) | 0% | 21.0 | 525,011 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2020 | 24,953 | 175,000 | - | - | Stock Option (Right to buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 58.00 per share. | 23 Dec 2020 | 47 | 504,504 (1%) | 0% | 58 | 2,726 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 23 Dec 2020 | 47 | 504,551 (1%) | 0% | 21.0 | 989 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2020 | 47 | 199,953 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 56.00 per share. | 21 Dec 2020 | 25,000 | 504,504 (1%) | 0% | 56 | 1,400,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 21 Dec 2020 | 25,000 | 529,594 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 25,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 21 Dec 2020 | 25,000 | 504,504 (1%) | 0% | 57 | 1,425,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 21 Dec 2020 | 25,000 | 529,504 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 21 Dec 2020 | 24,751 | 529,255 (1%) | 0% | 21.0 | 520,761 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 21 Dec 2020 | 24,751 | 504,504 (1%) | 0% | 55 | 1,361,305 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Dec 2020 | 24,751 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 50,249 | 49,751 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 53.51 per share. | 17 Dec 2020 | 50,249 | 504,504 (1%) | 0% | 53.5 | 2,688,824 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 17 Dec 2020 | 50,249 | 554,753 (1%) | 0% | 21.0 | 1,057,239 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 17 Dec 2020 | 25,000 | 504,504 (1%) | 0% | 50 | 1,250,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 25,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2020 | 25,000 | 0 | - | - | Stock Option (Right to buy) | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 52.00 per share. | 17 Dec 2020 | 25,000 | 504,504 (1%) | 0% | 52 | 1,300,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.04 per share. | 17 Dec 2020 | 25,000 | 529,504 (1%) | 0% | 21.0 | 526,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Sale of securities on an exchange or to another person at price $ 51.00 per share. | 17 Dec 2020 | 25,000 | 504,504 (1%) | 0% | 51 | 1,275,000 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.91 per share. | 17 Dec 2020 | 25,000 | 529,504 (1%) | 0% | 5.9 | 147,750 | Common stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.91 per share. | 17 Dec 2020 | 25,000 | 529,504 (1%) | 0% | 5.9 | 147,750 | Common Stock |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Sep 2020 | 10,000 | 504,504 (1%) | 0% | 0 | Common Stock | |
| Axonics Inc | Michael H. Carrel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2020 | 3,500 | 11,000 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Michael H. Carrel | Director, President, CEO, & Director | Grant, award, or other acquisition of securities at price $ 28.11 per share. | 30 Jun 2020 | 357 | 514,504 (1%) | 0% | 28.1 | 10,035 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges